Research Article
BibTex RIS Cite

Inverted Papilloma: Our Clinical Experiences

Year 2018, Volume: 1 Issue: 3, 67 - 69, 06.03.2019

Abstract

Objective: Inverted papilloma is a benign mass that usually originates from the sinonasal region in unilateral polypoid appearance. There is no significant factor in etiology, but the recent studies showing that it is related to human papillomavirus (HPV). The aim of the present study was to investigate the relationship between inverted papilloma and HPV. At the same time, the localization, stage, and hyperostosis findings of the tumor were evaluated.

Material and Methods: A total of 24 patients who underwent surgery for intranasal mass at the Adnan Menderes University Medical Faculty Department of Otorhinolaryngology-Head and Neck Surgery between 2013 and 2016 and whose pathology specimen were inverted papilloma evaluated retrospectively. In these patients, HPV positivity that was previously studied by the DNA polymerase chain reaction (PCR) method was noted and paranasal sinus computed tomography (PNS CT) imaging was evaluated.

Results: CT evaluation revealed hyperostosis in 14 (58%) patients, but not in 10 (42%) patients. All patients were diagnosed with HPV by molecular DNA PCR method. None of the patients had HPV positivity.

Conclusion: While inverted papilloma is radiologically evaluated by PNS CT, focal hyperostosis foci are important for detection of the origin of the tumor and surgical planning. More extensive studies are needed to demonstrate the effect of HPV in the process of inverted papilloma formation.

References

  • Lawson W, Patel ZM. The evolution of management for inverted papilloma: an analysis of 200 cases. Otolaryngol Head Neck Surg 2009; 140: 330-5.
  • Skolnik EM, Loewy A, Friedman JE. Inverted papilloma of the nasal cavity. Arch Otolaryngol 1966; 84: 61-7.
  • Govindaraj S, Wang H. Does human papilloma virus play a role in sinonasal inverted papilloma? Curr Opin Otolaryngol Head Neck Surg 2014; 22: 47-51.
  • Beck JC. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol - Head Neck Surg 1995; 113: 558-63.
  • Lawson W, Ho BT, Shaari CM, Biller HF. Inverted papilloma: a report of 112 cases. Laryngoscope 1995; 105: 282-8.
  • Krouse JH. Endoscopic treatment of inverted papilloma: safety and efficacy. Am J Otolaryngol 2001; 22: 87-99.
  • McCary WS, Gross CW, Reibel JF, Cantrell RW. Preliminary report: endoscopic versus external surgery in the management of inverting papilloma. Laryngoscope 1994; 104: 415-9.
  • Bugter O, Monserez DA, van Zijl FVWJ, Baatenburg de Jong RJ, Hardillo JA. Surgical management of inverted papilloma; a single-center analysis of 247 patients with long follow-up. J Otolaryngol Head Neck Surg 2017; 46: 67.
  • Salwa A. Sinonasal inverted papilloma: Evaluating the effectiveness of prediction of the site of attachment based on computed tomography scans. Clin Rhinol An Int J 2016; 9: 84-6.
  • Lee DK, Chung SK, Dhong HJ, Kim HY, Kim HJ, Bok KH. Focal hyperostosis on CT of sinonasal inverted papilloma as a predictor of tumor origin. AJNR Am J Neuroradiol 2007; 28: 618-21.
  • Zhao RW, Guo ZQ, Zhang RX. Human papillomavirus infection and the malignant transformation of sinonasal inverted papilloma: A meta-analysis. J Clin Virol 2016; 79: 36-43.
  • Beigh A, Rashi R, Junaid S, Khuroo MS, Farook S. Human Papilloma Virus (HPV) in Sinonasal Papillomas and Squamous Cell Carcinomas: A PCR-based Study of 60 cases. Gulf J Oncolog 2018; 1: 37-42.
  • Mohajeri S, Lai C, Purgina B, Almutairi D, Baghai T, Dimitroulakos J, et al. Human papillomavirus: An unlikely etiologic factor in sinonasal inverted papilloma. Laryngoscope 2018; doi: 10.1002/lary.27207.
  • Rooper LM, Bishop JA, Westra WH. Transcriptionally Active High-Risk Human Papillomavirus is Not a Common Etiologic Agent in the Malignant Transformation of Inverted Schneiderian Papillomas. Head Neck Pathol 2017; 11: 346-53.
There are 14 citations in total.

Details

Primary Language English
Subjects Otorhinolaryngology
Journal Section Research Article
Authors

Yaşar Can Akar This is me 0000-0002-9033-2206

Fatma Nur Yıldırım

Fürüzan Kaçar Döger This is me 0000-0002-6687-2966

Hatice Sema Başak 0000-0003-0687-975X

Publication Date March 6, 2019
Published in Issue Year 2018 Volume: 1 Issue: 3

Cite

APA Akar, Y. C., Yıldırım, F. N., Kaçar Döger, F., Başak, H. S. (2019). Inverted Papilloma: Our Clinical Experiences. European Journal of Rhinology and Allergy, 1(3), 67-69. https://doi.org/10.5152/ejra.2019.39
AMA Akar YC, Yıldırım FN, Kaçar Döger F, Başak HS. Inverted Papilloma: Our Clinical Experiences. Eur J Rhinol Allergy. March 2019;1(3):67-69. doi:10.5152/ejra.2019.39
Chicago Akar, Yaşar Can, Fatma Nur Yıldırım, Fürüzan Kaçar Döger, and Hatice Sema Başak. “Inverted Papilloma: Our Clinical Experiences”. European Journal of Rhinology and Allergy 1, no. 3 (March 2019): 67-69. https://doi.org/10.5152/ejra.2019.39.
EndNote Akar YC, Yıldırım FN, Kaçar Döger F, Başak HS (March 1, 2019) Inverted Papilloma: Our Clinical Experiences. European Journal of Rhinology and Allergy 1 3 67–69.
IEEE Y. C. Akar, F. N. Yıldırım, F. Kaçar Döger, and H. S. Başak, “Inverted Papilloma: Our Clinical Experiences”, Eur J Rhinol Allergy, vol. 1, no. 3, pp. 67–69, 2019, doi: 10.5152/ejra.2019.39.
ISNAD Akar, Yaşar Can et al. “Inverted Papilloma: Our Clinical Experiences”. European Journal of Rhinology and Allergy 1/3 (March2019), 67-69. https://doi.org/10.5152/ejra.2019.39.
JAMA Akar YC, Yıldırım FN, Kaçar Döger F, Başak HS. Inverted Papilloma: Our Clinical Experiences. Eur J Rhinol Allergy. 2019;1:67–69.
MLA Akar, Yaşar Can et al. “Inverted Papilloma: Our Clinical Experiences”. European Journal of Rhinology and Allergy, vol. 1, no. 3, 2019, pp. 67-69, doi:10.5152/ejra.2019.39.
Vancouver Akar YC, Yıldırım FN, Kaçar Döger F, Başak HS. Inverted Papilloma: Our Clinical Experiences. Eur J Rhinol Allergy. 2019;1(3):67-9.

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.